|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||8.77 - 8.77|
|52 Week Range||2.40 - 9.52|
|Beta (5Y Monthly)||1.64|
|PE Ratio (TTM)||∞|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for NURPFLearn more
Neuren Pharmaceuticals Ltd (ASX:NEU) CEO Jon Pilcher speaks with Proactive following the news that its North America partner Acadia Pharmaceuticals has received US Food and Drug Administration appr...
Neuren Pharmaceuticals Limited ( ASX:NEU ) is possibly approaching a major achievement in its business, so we would...